Navigation Links
Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
Date:7/7/2010

OXFORD, England, July 7, 2010 /PRNewswire-FirstCall/ -- Elsevier is pleased to announce the appointment of prominent new Editors-in-Chief to three key endocrinology titles, effective immediately.

Editor-in-Chief, Metabolism: Christos S. Mantzoros, MD DSc FACP FACE

Christos Mantzoros is clinical research lead at the Department of Endocrinology, Diabetes and Metabolism at Beth Israel Deaconess Medical Center, Boston, and associate professor of medicine at Harvard Medical School. He replaces James B. Field, who retires as Editor of Metabolism. Professor Mantzoros' research involves the discovery and elucidation of novel molecules central in the pathogenesis of diabetes, obesity, and related diseases. The Mantzoros group employs a wide range of basic, translational, and clinical approaches in this aim.

Editor-in-Chief, Primary Care Diabetes: Jaakko Tuomilehto, MD, PhD

Jaakko Tuomilehto succeeds Rhys Williams as Editor-in-Chief of Primary Care Diabetes. Professor Tuomilehto, University of Helsinki, has a broad and extensive experience in clinical epidemiology and genetic epidemiology of type 1 and type 2 diabetes. He is also an experienced coordinator of national studies in Finland and international collaborative studies, with a publishing record in excess of 900 papers comprising several landmark studies. Primary Care Diabetes is the official journal of Primary Care Diabetes Europe.

Editor-in-Chief, PLEFA: Richard P. Bazinet, PhD

Richard P Bazinet takes over the editorship of PLEFA (Prostaglandins, Leukotrienes and Essential Fatty Acids), from Mehar Manku, who remains as Editor Emeritus. Dr Bazinet, a former Associate Editor, is a researcher at the Faculty of Medicine, University of Toronto, and works to identify the mechanisms that regulate brain lipid metabolism and the role of brain lipid metabolism in the pathogenesis of neurodegenerative diseases and neuropsychiatric disorders. PLEFA is the official journal of the International Society for the Study of Fatty Acids and Lipids.

About Metabolism

This eminent journal ( http://www.elsevier.com/wps/find/journaldescription.cws_home/623319/descripti on#description) is regarded by clinicians and researchers alike as an authoritative source of practical information on metabolic processes and diseases in the areas of nutrition, genetics, dystrophies, diabetes and gout. Reviews and surveys on the status of research and practice in specific metabolic disorders are featured.

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

About Primary Care Diabetes

The journal ( http://www.elsevier.com/wps/find/journaldescription.cws_home/710796/descripti on#description) publishes original research articles and high quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology and other areas as far as is relevant for diabetology in a primary-care setting. The purpose of the journal is to encourage interdisciplinary research and discussion between all those who are involved in primary diabetes care on an international level. The Journal also publishes news and articles concerning the policies and activities of Primary Care Diabetes Europe and reflects the society's aim of improving the care for people with diabetes mellitus within the primary-care setting.

About Prostaglandins, Leukotrienes & Essential Fatty Acids (PLEFA) (http://www.elsevier.com/wps/find/journaldescription.cws_home/623065/descript ion#description) The role of lipids, including essential fatty acids and their prostaglandin, leukotriene and other derivatives, is now evident in almost all areas of biomedical science. Cell membrane behaviour and cell signalling in all tissues are highly dependent on the lipid constituents of cells. Prostaglandins, Leukotrienes and Essential Fatty Acids aims to cover all aspects of the roles of lipids in cellular, organ and whole organism function, and places a particular emphasis on human studies. Papers concerning all medical specialties are published. Much of the material is particularly relevant to the development of novel treatments for disease.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Andrew Miller
    Executive Publisher, Elsevier
    Tel.: +44(0)1865-843823
    andrew.miller@elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Appoints Martin OMalley as Managing Director of New Global Sales Group in Science & Technology Division
2. Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course
3. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
4. Gold Standard/Elsevier Launches Clinical Pharmacology Mobile
5. InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools
6. Elsevier is Meeting Todays Medical Students Needs With Online, Mobile and Print Tools
7. Elsevier Selects BrainTrack Directory as Supplier of College Data
8. Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States
9. Elsevier is Expanding eClinical Solutions in Europe
10. Avrio Appoints David L. Gelber to Director of Manufacturing
11. Accuray Appoints Peter Fine to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):